Optimization of echocardiographic quantification of aortic regurgitation against CMR: novel algorithm development and prospective validation

优化超声心动图定量主动脉瓣反流与心脏磁共振成像的比较:新型算法开发及前瞻性验证

阅读:1

Abstract

AIMS: Cardiac magnetic resonance (CMR) compliments transthoracic echocardiography (TTE) for heart valve evaluation, however TTE remains more widely available. We sought to optimize TTE quantification of significant aortic regurgitation (AR) by developing TTE-based algorithms to identify CMR-defined severe AR. METHODS AND RESULTS: Patients with moderate-to-severe AR undergoing both TTE and CMR within 3-months were studied. A historical cohort 2006-18 (n = 193) was used to derive TTE-based decision tree regression algorithms to best identify severe AR based on holodiastolic flow reversal (HDR) using CMR, then validated in a prospective AR cohort (n = 97) during 2019-21.Mean AR regurgitant volumes, fractions, and proportions with HDR by TTE/CMR were 48/31 mL, 41/25%, and 43%/27% for the historical derivation cohort and 51/37 mL, 47/29%, and 54%/41% for the prospective validation cohort. Decision-tree analyses found regurgitant volume ≥ 45 mL and left ventricular end-diastolic volume index (LVEDVi) ≥ 93 mL/m2 by TTE to best identify CMR-derived severe AR. Areas under curves (95%CIs) of the novel algorithms (proximal isovelocity surface area and Doppler methods) compared with current guidelines criteria for detecting CMR-derived severe AR were 0.80 (0.71-0.88) and 0.74 (0.65-0.83) vs. 0.72 (0.63-0.81) in the derivation cohort, and 0.76 (0.66-0.87) and 0.71 (0.61-0.82) vs. 0.58 (0.46-0.70) in the validation cohort; and for predicting left ventricular remodelling where follow-up TTE wad available were 0.65 (0.58-0.73) and 0.62 (0.55-0.70) vs. 0.53 (0.45-0.61), respectively. CONCLUSION: Novel TTEs algorithm increased TTE accuracy of identifying significant AR defined by CMR especially in the prospective cohort, compared to the current guidelines criteria, and was able to modestly discriminate LV remodelling.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。